pmc logo image
Logo of mendMEND HomepageTES HomepageSubscriptionsSubmissionAbout MEND
Journal List > Mol Endocrinol

Formats:
Mol Endocrinol. 2008 December; 22(12): 2596–2608.
Published online 2008 October 22. doi: 10.1210/me.2008-0161.
PMCID: PMC2610364
HHMIMSID: HHMIMS81894
Copyright © 2008 by The Endocrine Society
Inhibition of Adipocyte Differentiation by Nur77, Nurr1, and Nor1
Lily C. Chao, Steven J. Bensinger, Claudio J. Villanueva, Kevin Wroblewski, and Peter Tontonoz
Howard Hughes Medical Institute (L.C.C., S.J.B., C.J.V., K.W., P.T.), Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California 90095-1662; and The Center for Diabetes, Endocrinology and Metabolism (L.C.C.), Childrens Hospital Los Angeles, University of Southern California, Los Angeles, California 90027
Address all correspondence and requests for reprints to: Peter Tontonoz M.D., Ph.D., Howard Hughes Medical Institute, University of California Los Angeles School of Medicine, Box 951662, Los Angeles, California 90095-1662. E-mail: ptontonoz/at/mednet.ucla.edu.
Received May 16, 2008; Accepted October 15, 2008.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
Members of the nuclear receptor 4A (NR4A) subgroup of nuclear receptors have been implicated in the regulation of glucose and lipid metabolism in insulin-sensitive tissues such as liver and skeletal muscle. However, their function in adipocytes is not well defined. Previous studies have reported that these receptors are rapidly up-regulated after treatment of 3T3-L1 preadipocytes with an adipogenic cocktail. We show here that although Nur77 expression is acutely induced by cAMP agonists in 3T3-L1 cells, it is not induced by other adipogenic stimuli, such as peroxisome proliferator-activated receptor-γ ligands, nor is it induced during the differentiation of 3T3-F442A preadipocytes, suggesting that Nur77 induction is not an obligatory feature of preadipocyte differentiation. We further demonstrate that inflammatory signals that antagonize differentiation, such as TNFα and lipopolysaccharide, acutely induce Nur77 expression both in vitro and in vivo. We also show that NR4A expression in adipose tissue is responsive to fasting/refeeding. Retroviral transduction of each of the NR4A receptors (Nur77, Nurr1, and NOR1) into either 3T3-L1 or 3T3-F442A preadipocytes potently inhibits adipogenesis. Interestingly, NR4A-mediated inhibition of adipogenesis cannot be rescued by peroxisome proliferator-activated receptor-γ overexpression or activation. Transcriptional profiling of Nur77-expressing preadipocytes led to the identification of gap-junction protein α1 (Gja1) and tolloid-like 1 (Tll1) as Nur77-responsive genes. Remarkably, retroviral expression of either Gja1 or Tll1 in 3T3-L1 preadipocytes also inhibited adipocyte differentiation, implicating these genes as potential mediators of Nur77’s effects on adipogenesis. Finally, we show that Nur77 expression inhibits mitotic clonal expansion of preadipocytes, providing an additional mechanism by which Nur77 may inhibit adipogenesis.
 
STUDIES UTILIZING various in vitro preadipocyte cell lines, mouse embryonic fibroblasts, and in vivo murine models have revealed adipogenesis to be a well-orchestrated process marked by changes in cell proliferation/differentiation and the sequential induction of key transcription factors. In the 3T3-L1 preadipocyte cell line originally isolated from nonclonal Swiss 3T3 cells (1,2,3), proliferation of preadipocytes ceases upon confluence. The addition of commonly used differentiation cocktail, consisting of dexamethasone, phosphodiesterase inhibitor, and insulin, triggers mitotic clonal expansion, which appears to be an essential aspect of adipogenesis in 3T3-L1 cell line. After one to two rounds of mitosis, growth arrest occurs again, and early adipogenic transcription factors such as CCAAT enhancer binding protein (C/EBP)β and C/EBPδ are expressed (4,5). These two proteins subsequently induce the up-regulation of peroxisome proliferator-activated receptor (PPAR)γ, the master transcriptional regulator of adipogenesis (6,7). PPARγ drives the expression of C/EBPα, which in a positive feedback loop further amplifies the expression of the former. These factors contribute to the phenotype of triglyceride accumulation and the expression of differentiation-dependent metabolic genes such as fatty acid binding protein 4 (also known as aP2), adiponectin, phosphoenol pyruvate carboxykinase, and the insulin-sensitive glucose transporter 4.
Among transcription factors that regulate metabolism, nuclear receptors are particularly important in coordinating changes in environmental milieu with downstream metabolic pathways in insulin-sensitive tissues. A newcomer to this group is the orphan nuclear receptor 4A (NR4A) subfamily. The NR4A subfamily consists of three isotypes, commonly known as Nur77, Nurr1, and NOR1 (NR4A1, 2, and 3). These receptors have pleotropic functions ranging from suppression of leukemogenesis to dopaminergic neuron development (8,9,10,11). In recent years, the NR4A receptors have also been established as transcriptional regulators of hepatic gluconeogenesis (12). In skeletal muscle, these receptors regulate the expression of glucose utilization as well as oxidative phosphorylation genes (13,14). However, the function of NR4A receptors in adipocytes is relatively poorly understood.
Recently, Fu et al. (15) reported that preadipocyte expression of NR4A receptors was induced within 30 min of treatment by either standard differentiation cocktail [dexamethasone, isobutylmethylxanthine (IBMX), and insulin] or the PPARγ ligand rosiglitazone. Others have reported, however, that induction of NR4A receptors occurs some 24–48 h after the addition of the PPARγ ligands troglitazone or pioglitazone to fully differentiated adipocytes (16). On the other hand, Au et al. (17) have suggested that NR4A receptors are not required for adipogenesis. Collectively, these studies raise the possibility that the NR4As may be involved in the regulation of adipocyte gene expression during differentiation. However, no target genes for NR4As in adipocytes have yet been described. Moreover, the precise function of NR4A receptors in adipogenesis remains unclear.
To address NR4A functions in adipogenesis, we generated stable 3T3-L1 and 3T3-F442A preadipocyte cell lines overexpressing each of the three NR4A receptors. Unexpectedly, expression of the NR4A receptors strongly inhibited differentiation. Furthermore, NR4A-mediated inhibition of adipogenesis could not be rescued by overexpression of PPARγ or by treatment with a PPARγ ligand. We also identified and validated two potential mediators of this process: gap-junction protein, α1 (Gja1) and tolloid-like 1 (Tll1). Finally, we showed that NR4A1 expression disrupted mitotic clonal expansion in 3T3-L1 cells, providing another mechanism by which NR4A receptors inhibit adipogenesis.
RESULTS
Nur77 Expression during Preadipocyte Differentiation
Previous work on NR4A receptors in adipogenesis suggested that these receptors are rapidly induced upon differentiation, in response to either standard differentiation cocktail (DMI) consisting of dexamethasone, IBMX, and insulin, or a PPARγ ligand (15). As NR4A receptors are positively regulated by cAMP-responsive element binding protein (18,19), the rapid and transient up-regulation of NR4A in response to adipogenic cocktail likely reflects increased extracellular cAMP concentration induced by the phosphodiesterase inhibitor IBMX. Furthermore, NR4A receptors are inducible by various growth factors and may be responsive to changes in media (20,21).
We examined the expression of Nur77 in response to the standard differentiation cocktail (DMI) or PPARγ ligand GW7845 and insulin in 3T3-L1 preadipocytes. To avoid fluctuations in Nur77 expression due to serum refreshment, chemicals were diluted in serum-free DMEM and added to cells in volumes less than 1% of total media volume. As shown in Fig. 1A 1A,Figure 1, Nur77 mRNA was rapidly but transiently induced in response to DMI within 1 h of differentiation. Nur77 protein level peaked at 2 h and remained elevated 8 h after addition of 8-bromo-cAMP (8-Br-cAMP) (Fig. 1B 1B).Figure 1). The addition of GW7845 and insulin resulted in minimal change in Nur77 expression. We also examined the expression of Nur77 in 3T3-F442A preadipocytes, which requires only insulin for adipogenesis. As Fig. 1C 1CFigure 1 shows, Nur77 is not up-regulated within the early hours of differentiation in 3T3-F442A cells. Expression of the fatty acid binding protein aP2 is shown as a marker of adipocyte differentiation for both 3T3-L1 and 3T3-F442A cells.
Figure 1
Figure 1
Figure 1
Induction of Nur77 Expression by cAMP Signaling during Adipogenesis
To further delineate the component in DMI that may account for the induction of Nur77 observed in Fig. 1A 1A,Figure 1, 3T3-L1 preadipocytes were treated for 1 h with PBS, 0.5 μg/ml insulin, 1 μm dexamethasone, or 0.5 mm IBMX. As suspected, the rapid induction of Nur77 as well as the other NR4A isotypes in differentiating 3T3-L1 cells occurred in response to IBMX (Fig. 1D 1D).Figure 1). Of note, Nur77 expression was also slightly increased by insulin, which likely accounts for the increase in Nur77 in 3T3-L1 cells treated with GW7845/insulin. To confirm that PPARγ ligands do not induce NR4A expression, 3T3-L1 preadipocytes were incubated for 1 h with various combinations of PPARγ agonists (GW7845, BRL/rosiglitazone) and antagonist (GW9662). As shown in Fig. 1E 1E,Figure 1, none of the PPARγ ligands was capable of inducing NR4A receptor expression. 8-Br-cAMP was included as a positive control. These data demonstrate that early up-regulation of NR4A receptors observed during adipocyte differentiation reflects cAMP-mediated regulation of these receptors. Furthermore, although insulin may contribute to the increase in Nur77 expression during adipogenesis, PPARγ activation alone has no significant effect on Nur77 expression.
Nur77 Is Induced by Inflammatory Signals in Adipocytes
Inflammatory signals such as TNFα and lipopolysaccharide (LPS) are known inhibitory factors in adipogenesis (22,23). In addition, TNFα, LPS, and other proinflammatory stimuli have been shown to be potent inducers of Nur77 in macrophages (24,25). We therefore examined whether these inflammatory triggers can induce Nur77 expression in adipocytes. In 3T3-L1 preadipocytes, various inflammatory stimuli were added directly to the culture media, to minimize serum-induced fluctuation of Nur77. As shown in Fig. 2A 2A,Figure 2, Nur77 was induced approximately 2-fold by TNFα and LPS in 3T3-L1 preadipocytes. To determine whether Nur77 is similarly up-regulated in vivo, wild-type C57Bl/6 mice were injected with PBS or LPS (5 mg/kg). Epididymal white adipose tissue was isolated and flash frozen 1 h after injection. Total RNA preparation from the adipose tissue revealed that, compared with PBS-injected controls, LPS robustly up-regulated Nur77 expression (Fig. 2B 2B).Figure 2). This finding suggests that one plausible physiological function of Nur77 is to mediate inflammation-induced inhibition of lipid accumulation and adipogenesis.
Figure 2
Figure 2
Figure 2
NR4A Expression Is Induced by Inflammatory Stimuli in Vitro and in Vivo
Fasting Induces Expression of NR4A Receptors
We have previously demonstrated that fasting potently induces hepatic NR4A receptor expression to enhance gluconeogenesis (12). To determine whether NR4A receptors are similarly up-regulated in white adipose tissue in response to fasting, we measured NR4A expression of epididymal fat pads from fasted and fasted/refed wild-type and ob/ob mice. As shown in Fig. 3 3,Figure 3, Nur77 and NOR1 expression was markedly reduced in the fed state. Nurr1 expression did not appear to be down-regulated by refeeding. Interestingly, ob/ob mice appeared to lack the feeding-regulated suppression of Nur77 and NOR1.
Figure 3
Figure 3
Figure 3
NR4A Expression in White Adipose Tissue
NR4A Overexpression Inhibits Adipogenesis
NR4A receptors have been shown to mediate various metabolic processes in insulin-sensitive tissues such as liver and skeletal muscle (12,13,14,26,27). To determine the function of NR4A receptors in adipocytes, we first tested their roles in differentiation. Using retroviral transduction, each of the three NR4A isotypes was stably overexpressed in 3T3-L1 preadipocytes. As an additional control, we also tested the effect of Nur77–898, an N-terminally truncated dominant-negative receptor (deletion of the first 897 nucleotides of Nur77). Deletion of the N-terminal transactivation domain has previously been shown to antagonize the activity of all three NR4A isotypes (12,17,28). After puromycin selection of large mixed pool of cells (not single clones), each cell line was differentiated in standard differentiation cocktail for 7 d (DMI for 2 d, followed by insulin alone for 5 d). As shown in Fig. 4 4,Figure 4, expression of each of the NR4A receptors, but not Nur77–898, strongly inhibited adipogenesis of 3T3-L1 preadipocytes (Fig. 4 4,Figure 4, top row). Similar results were obtained with multiple independent sets of stable lines.
Figure 4
Figure 4
Figure 4
NR4A Receptors Inhibit the Differentiation of 3T3 Preadipocytes
Our finding that NR4A receptors inhibit adipogenesis was reproduced in 3T3-F442A cells (Fig. 4 4,Figure 4, second row) as well as in C3H10T1/2 cells (data not shown). Even more striking was the observation that treatment of the NR4A-expressing 3T3-L1 preadipocytes with the PPARγ ligand GW7845 (in addition to the standard DMI cocktail) was unable to rescue adipogenesis (Fig. 4 4,Figure 4, third row). Likewise, NR4A-mediated inhibition of adipogenesis in 3T3-L1 preadipocytes could not be overcome even when PPARγ was ectopically expressed (Fig. 4 4,Figure 4, bottom row). These data identify NR4A receptors as regulators of adipogenesis. The observation that PPARγ activation is unable to rescue adipogenesis in NR4A-expressing 3T3-L1 preadipocytes suggests that NR4A receptors regulate a PPARγ-independent pathway in adipogenesis (see below).
Examination of the expression of early adipogenic transcription factors revealed that C/EBPβ and C/EBPδ were expressed at lower levels in 3T3-L1 preadipocytes overexpressing Nur77 (Fig. 5A 5A).Figure 5). We observed an increase in expression of GATA2, a known inhibitor of adipogenesis (29), 24 h after DMI induction in Nur77-expressing cells. There was also a subtle increase in expression of PPARγ 24 h after DMI treatment. Given the minimal expression level of PPARγ at this time point, the change is likely of little biological significance. Expression of Pref-1, another inhibitor of adipogenesis (30,31), was unaffected (Fig. 5B 5B).Figure 5). The changes in expression of these early adipocyte transcription factors suggest that Nur77 is acting within 24 h of induction of differentiation.
Figure 5
Figure 5
Figure 5
Expression of Adipogenic (A) and Antiadipogenic (B) Transcription Factors in 3T3-L1 Cells Overexpressing Nur77
Acute Expression of Nur77 Does Not Cause Dedifferentiation of Adipocytes
Having demonstrated that chronic overexpression of NR4A receptors inhibits the differentiation of preadipocytes, we proceeded to determine whether ectopic Nur77 expression in mature adipocytes would lead to dedifferentiation. 3T3-L1 cells that express the human (h) coxsackie-adenovirus receptor (hCAR; courtesy of B. Spiegelman) were differentiated into mature adipocytes in the presence of standard adipogenic cocktail and GW7845 for 6 d. After differentiation, cells were maintained in 10% fetal bovine serum (FBS)/DMEM and 0.5 μg/ml insulin. Adipocytes were then infected overnight with adenovirus expressing either the green fluorescent protein (GFP) control or Nur77. Cells were harvested on d 5, 10, or 15 after infection for RNA isolation. As shown in Fig. 6 6,Figure 6, the expression of adipocyte markers such as PPARγ and aP2 was unaffected by acute ectopic expression of Nur77. This finding indicates that although Nur77 inhibits preadipocyte differentiation, it has no apparent effect on maintaining the phenotypic markers of mature adipocytes.
Figure 6
Figure 6
Figure 6
Acute Nur77 Expression Does Not Cause Dedifferentiation of 3T3-L1 Adipocytes
Identification of Nur77-Target Genes that Inhibit Adipogenesis
To identify putative Nur77 targets that may mediate its inhibitory effect on adipogenesis, we performed expression profiling of control (retrovirally transduced with empty vector) or Nur77-expressing 3T3-L1 preadipocytes. Total RNA was harvested at confluence or 24 h after DMI/GW7845 treatment. Genes induced greater than 5-fold by Nur77 are shown in supplemental Table 1 published as supplemental data on The Endocrine Society’s Journals Online web site at http://mend.endojournals.org. Several genes that are induced greater than 2-fold and are involved in adipogenesis are also included in this list. Induction of selected genes relevant to adipogenesis was verified by quantitative real-time PCR (supplemental Table 1). Among the genes shown in supplemental Table 1, gap junction protein, α1 (Gja1), tolloid-like 1 (Tll1), and WNT1-inducible signaling pathway protein 2 (Wisp2) were three particularly interesting genes that were induced by Nur77 in stable 3T3-L1 transformants both at baseline as well as at 24 h after differentiation induction. Gja1 is a member of the connexin family and is the major gap junction protein in the heart involved in synchronous contraction of the myocardium (32,33). It has also been shown to influence mitotic clonal expansion or 3T3-L1 preadipocytes (34). Tll1, an astacin-like metalloprotease with structural similarity to bone morphogenetic protein-1, is crucial for normal cardiac septation in mice (35). Although it is among the most highly induced gene in our microarray, Tll1 was not previously described to have a function in adipose tissue. Wisp2, a known downstream target of Wnt signaling (36), was also a plausible candidate to effect Nur77-driven inhibition of adipogenesis. Wisp2 expression was previously shown to be down-regulated during adipogenic differentiation of human bone marrow-derived mesenchymal stem cells (37).
As shown in Fig. 7A 7A,Figure 7, we verified with real-time PCR that Gja1, Tll1, and Wisp2 were up-regulated by Nur77 in stable 3T3-L1 transformants. To determine whether the induction in gene expression was responsive to acute as well as chronic overexpression of Nur77, the expression of Gja1, Tll1, and Wisp2 was further analyzed in 3T3-L1 hCAR adipocytes acutely infected with GFP- or Nur77-expressing adenovirus. The data of Fig. 7B 7BFigure 7 confirmed that these genes were robustly up-regulated by Nur77, suggesting that they are likely direct targets of the receptor.
Figure 7
Figure 7
Figure 7
Nur77 Induces the Expression of Gja1, Tll1, and Wisp2
We next determined whether ectopic expression of Gja1, Tll1, and Wisp2 was sufficient to inhibit adipogenesis in 3T3-L1 preadipocytes. The cDNA encoding each of these genes was PCR amplified and inserted into vectors for retroviral transduction of 3T3-L1 cells. After puromycin selection, cells were differentiated using standard adipogenic cocktail for 7 d. Oil red O staining revealed that ectopic expression of Gja1 and Tll1 inhibited adipogenesis, whereas Wisp2 overexpression had no effect (Fig. 8A 8A).Figure 8). The paucity of lipid droplet accumulation in Gja1- and Tll1-expressing cells was accompanied by diminished expression of adipogenic markers such as aP2, adipsin, lipoprotein lipase, and PPARγ (Fig. 8B 8B).Figure 8). Similar results were obtained with multiple independent sets of stable lines. Although neither Gja1 nor Tll1 diminished differentiation of 3T3-L1 cells to the same extent as Nur77, their ability to independently inhibit adipogenesis strongly suggests that they contribute to Nur77’s inhibitory activity on adipogenesis.
Figure 8
Figure 8
Figure 8
Expression of Gja1 or Tll1 Inhibits Adipogenesis
Nur77 Inhibits Mitotic Clonal Expansion
A prerequisite for 3T3-L1 adipocyte differentiation appears to be mitotic clonal expansion, during which quiescent cells synchronously cross the G1/S checkpoint and undergo mitosis within 24–60 h after differentiation cocktail treatment (38). Our gene expression data of 3T3-L1 Nur77-expressing cells showed that changes in adipogenic transcriptional programs were already underway by 24 h after DMI treatment (Fig. 5 5),Figure 5), suggesting that Nur77 imparts its inhibitory effect on adipogenesis early during the differentiation process. We therefore tested the hypothesis that Nur77 may inhibit adipogenesis, in part, by preventing mitotic clonal expansion.
To first determine whether Nur77 alters proliferation of actively dividing 3T3-L1 cells, 50,000 cells were plated in one well of a six-well dish. Total cell number was determined 20 h after plating. As Fig. 9A 9AFigure 9 shows, control and Nur77-expressing 3T3-L1 cells both doubled their cell number, indicative of approximately one round of cell division. However, 42 h after DMI treatment, Nur77-expressing 3T3-L1 cells had only half the number of cells as controls, consistent with diminished mitosis. Gja1 expression had no effect on DMI-induced cell division (Fig. 9B 9B).Figure 9). We next performed flow cytometric analysis at different time points after DMI treatment to more precisely determine the percentage of cells acquiring diploid (2n) DNA content. At confluence, approximately 27% of empty vector- and Nur77–898- (N terminus-truncated Nur77) expressing 3T3-L1 cells acquired 2n DNA content, whereas 23% of Nur77-expressing cells contained 2n DNA (Fig. 9C 9C).Figure 9). As expected, 13 h after DMI treatment, the percentage of cells acquiring 2n DNA content had increased to 45% for control cells (empty vector only and Nur77–898). Remarkably, Nur77 cells seemingly failed to escape from G0/G1 interphase, as the percentage of cells with 2n DNA persisted at approximately 25%. All three cell lines exited cell cycle by 40 h after DMI induction, with only 20–25% of cells having 2n DNA content. Our data thus suggest that one mechanism by which Nur77 inhibits adipogenesis in 3T3-L1 cells is by arresting mitotic clonal expansion.
Figure 9
Figure 9
Figure 9
Nur77 Inhibits Mitotic Clonal Expansion
DISCUSSION
Recent studies have identified NR4A receptors as regulators of metabolism in insulin-sensitive tissues such as liver and skeletal muscle (12,13,26). Here we outline a function for NR4A receptors as inhibitors of adipogenesis. We demonstrated that the previously reported acute induction of NR4A expression early in 3T3-L1 adipogenesis occurs in response to cAMP signaling, but not to PPARγ ligand. We also presented data showing that in white adipose tissue, NR4A expression is responsive to both inflammatory signals as well as fasting/refeeding. In addition, we showed that stable NR4A expression in several preadipocyte cell lines inhibits adipogenesis, even in the presence of exogenous PPARγ activation or ectopic PPARγ expression. We identified Gja1 and Tll1 as two putative NR4A target genes that may mediate NR4A’s inhibitory effect on adipose differentiation. In addition to the effect imposed by these two genes, Nur77 also inhibited adipogenesis by limiting mitotic clonal expansion.
Fu et al. (15) have reported that NR4A receptors are induced within 30 min of treating 3T3-L1 preadipocytes with either standard differentiation cocktail or PPARγ ligand, suggesting that these receptors are positive regulators of adipogenesis. Our findings demonstrate that whereas NR4A receptors are up-regulated in 3T3-L1 cells within 60 min of receiving standard adipogenic cocktail, induction occurs in response to the increase in cAMP signaling triggered by the adipogenic cocktail and may not be an intrinsic aspect of adipogenesis per se. This is supported by our data that Nur77 expression was not significantly altered in 3T3-L1 cells differentiated with insulin and PPARγ ligand, whereas 8-Br-cAMP or IBMX treatment caused an acute rise in Nur77 expression. Furthermore, PPARγ ligand treatment had no acute effect on the expression of NR4A receptors. NR4A receptor expression was also not induced during the differentiation of 3T3-F442A cells. Our observations are consistent with the time frame required for nuclear receptors to be activated by ligand and to exert downstream transcriptional regulation—likely hours rather than minutes. Because NR4A receptors are immediate-early genes inducible by various mitogens, it is plausible that previous observations that PPARγ ligands acutely inducing NR4A expression may be explained by the effects of serum refreshment.
Our laboratory previously showed that inflammatory signals rapidly up-regulate the expression of NR4A receptors in macrophages (24,25). In the present work we have extended this observation to 3T3-L1 preadipocytes as well as white adipose tissue isolated from wild-type mice. Because inflammation-mediated inhibition of adipose differentiation is a well-described process (22,23,39), we speculate that one physiological function of NR4A receptors in adipose tissue may be to mediate the metabolic and/or antitrophic effects of inflammation on adipogenesis. Because the three NR4A receptors exhibit functional redundancy, this hypothesis cannot be easily studied in vivo in single NR4A knockout mouse models. Adipose-specific NR4A knockout or transgenic mouse models will likely be required to test this hypothesis.
Similar to our previous findings in the liver, we showed here that Nur77 and NOR1 were up-regulated in adipose tissue in the fasted state. That expression of NR4A receptors responds to nutritional status is consistent with our theory that these receptors mediate physiological processes to increase energy delivery to the organism (13). It is thus reasonable to posit that NR4A receptors may mediate lipolysis in adipose tissue. In fact, the lack of fasting/feeding-induced changes in NR4A expression in ob/ob mice we observed is akin to the impaired lipolysis exhibited by these mice (40,41,42). Using the dominant-negative Nur77 receptor, we examined whether disruption of NR4A function would prevent lipolysis in vitro. At least in 3T3-L1 adipocytes, NR4A function appears to be dispensable for isoproterenol- and TNFα-mediated lipolysis (supplemental Fig. 1 published as supplemental data on The Endocrine Society’s Journals Online web site at http://mend.endojournals.org), suggesting that NR4A function is not necessary for β3-adrenergic receptor- or TNFα-induced lipolysis.
In contrast to previous suggestions that NR4A signaling may promote adipocyte differentiation, we find that NR4A receptors are potent inhibitors of adipogenesis. That NR4A receptors are induced by cAMP response element binding protein, and cAMP response element binding protein signaling is required for adipogenesis, are not necessarily contradictory processes (43,44). We showed that Nur77 expression led to early changes in the expression of several transcriptional factors such as C/EBPβ, C/EBPδ, and GATA2. This finding suggests that NR4A receptors exert their inhibitory effect on adipogenesis at an early time point, and there may be a window of opportunity beyond which NR4A expression no longer impacts the differentiation process.
One mechanism by which Nur77 may inhibit adipogenesis is by preventing mitotic clonal expansion (Fig. 9 9).Figure 9). At present, however, it remains unclear whether Nur77 affects clonal expansion by altering the expression and/or activity of early adipogenic transcription factors, the expression of gap junction proteins, or through other unknown mechanisms. Previous studies showed that disruption of C/EBPβ activity blocks mitotic clonal expansion in 3T3-L1 cells (45,46,47). The observation that Nur77 overexpression reduced C/EBPβ and C/EBPδ transcript levels by 24 h after hormonal induction suggests that interruption of clonal expansion may reflect diminished promoter activity of C/EBPβ or C/EBPδ. One also cannot exclude that possibility that Nur77 directly alters C/EBPβ and C/EBPδ activity. Additional work is ongoing to investigate these scenarios.
Previous studies of cell-to-cell communication of 3T3-L1 preadipocytes have shown that gap junction activity decreases during adipogenesis (34,48). This decline in cell-to-cell communication appears to occur at the time when spindle-shaped fibroblasts become more rounded and begin lipid accumulation (48). Our observation that expression of the Nur77-responsive gene Gja1 inhibited adipogenesis is thus consistent with the previously published observation that unremitting gap junction activity prevents adipogenesis. Interestingly, Yanagiya and colleagues (34) showed that abrogation of Gja1 expression by small interfering RNA reduced mitotic clonal expansion as well as adipogenesis. This finding suggests that, at least in 3T3-L1 fibroblasts, there may be an optimal window during which gap junction proteins are critical for clonal expansion, such that either constitutive loss- or gain-of-function interrupts normal mitotic clonal expansion and adipogenic programming.
Although inhibition of mitotic clonal expansion represents one pathway by which Nur77 may negatively regulate adipogenesis, there are likely other mechanisms involved. Modulation of extracellular matrix through metalloproteases (49,50) or cell-cell signaling molecules such as integrins (51,52) has been shown to regulate adipose differentiation. One might thus hypothesize that Nur77-mediated induction of Tll1 may inhibit adipogenesis by affecting the remodeling of extracellular matrix. In addition, although we stably overexpressed a select set of genes induced by Nur77 in 3T3-L1 preadipocytes, there may be additional Nur77 targets that we have not tested, which may also affect adipogenesis. Notably, this list (supplemental Table 1) includes many extracellular matrix proteins as well as adhesion molecules. Future studies are necessary to further define Nur77-regulated pathways that may impact adipogenesis.
MATERIALS AND METHODS
Reagents
Synthetic ligands GW7845 and GW9662 were provided by Jon Collins and Timothy Willson (GlaxoSmithKline, Research Triangle Park, NC). Ligands were dissolved in DMSO before use in cell culture.
Cell Culture
We purchased human embryonic kidney (HEK)293T and 3T3-L1 cells from American Type Culture Collection (Manassas, VA). 3T3-F442A cells were a gift from E. Saez. HEK293T cells were maintained in 10% FBS (Omega Scientific, Stamford, CT) in DMEM at 8% CO2. 3T3-L1 and 3T3-F442A cells were maintained and differentiated as previously described (53). 3T3-L1 hCAR cells (gift from B. Spiegelman) were differentiated as described for 3T3-L1 cells, except that 100 nm GW7845 was added to the culture media during differentiation. For adenovirus infection, cells were cultured with adenovirus at a multiplicity of infection of 250 in 10% FBS/0.5 μg/ml insulin overnight before media refreshment the next day. Oil Red O staining was performed as described (7).
Stable Cell Lines
Full-length cDNA of murine Nur77, Nurr1, NOR1, Nur77–898 (cDNA starts at nucleotide +898), Gja1, Tll1, Wisp2 genes was PCR amplified and cloned into MSCV-pac plasmid. Expression plasmids along with ecotropic helper plasmid were transiently transfected into HEK293T cells using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). Supernatant was sterile filtered 2 d after transfection and added to either 3T3-L1 or 3T3-F442A cells. Puromycin (4 μg/ml) in 10% calf serum was used for selection of stable clones. 3T3-L1 cells overexpressing PPARγ were selected with hygromycin (50 μg/ml).
Quantitative Real-Time PCR
Total RNA was isolated with Trizol (Invitrogen). cDNA was synthesized using reverse transcriptase from Applied Biosystems (Foster City, CA). Real-time PCR was performed as described previously (13). See supplemental Table 2 for a complete list of primer sequences used in real-time PCR.
Microarrays
RNA from control (empty vector) or Nur77-expressing 3T3-L1 cells was harvested at confluence (time zero) or 24 h after DMI/GW7845 (100 nm) treatment. Total RNA prepared by Trizol was further purified through RNEasy columns (QIAGEN, Chatsworth, CA). Each condition was done with replicate arrays, each representing three pooled wells. cRNA preparation and hybridization to Affymetrix Mouse Genome Arrays 430 version 2.0 was performed by the UCLA Microarray Core, and data were analyzed using GeneSpring GX7.3.1. We included only genes with raw data signal greater than 500 for at least one condition for analysis.
Cell Cycle Analysis
Cells (50,000 per well) were plated on gelatin-coated six-well plates. Cells were trypsinized before cell counting and staining. Using the Z1 Coulter Counter (Beckman Coulter, Inc., San Jose, CA), we averaged the mean of cell counts from two independent aliquots per well. Staining of DNA content was performed as previously described (54). Briefly, we resuspended PBS-washed cells in PBS containing 0.1% sodium citrate (wt/vol) (Sigma Chemical Co., St. Louis, MO), 0.3% Triton X-100 (vol/vol) (Sigma), 0.01% propidium iodide (wt/vol) (Calbiochem, La Jolla, CA), and 0.002% ribonuclease A (wt/vol) (Sigma), and incubated the cells for 30 min at 20–25 C. We acquired cell cycle data on a FACS Calibur (BD Biosciences, Palo Alto, CA). Data were analyzed using FloJo Software (Tree Star, Inc., Ashland, OR).
Animals
We purchased age-matched C57Bl/6 wild-type and ob/ob male mice from The Jackson Laboratory (Bar Harbor, ME). Mice were provided with water and standard mouse chow ad libitum and were maintained on 12-h light cycle. PBS or lipopolysaccharide (5 mg/kg) was injected into the peritoneum. Mice were euthanized by isoflurane exactly 1 h after injection. Epididymal adipose tissue was isolated and flash frozen in liquid nitrogen. Total RNA was prepared as described previously (13).
Lipolysis Assay
3T3-L1 hCAR cells were differentiated as described above for 5–7 d. Adipocytes were then infected with adenovirus expressing either GFP or Nur77–898 in 10% FBS/DMEM at a multiplicity of infection of 250, before media refreshment the next day (10% FBS/DMEM). Lipolysis assay was performed as described elsewhere (55).
Immunoblot
3T3-L1 preadipocytes were grown to confluence and treated with 1 mm 8-Br-cAMP. Nuclear extract was prepared as follows: cells were scraped and pelleted in PBS, and washed in cold buffer A (10 mm HEPES, pH 7.9; 10 mm KCl; 0.1 mm EGTA; 0.1 mm EDTA; 1 mm dithiothreitol; 0.5 mm phenylmethylsulfonylfluoride; protease inhibitor) and resuspended in buffer A. After 15 min on ice, Nonidet P-40 was added to the cells to a final concentration of 5.9%. After vigorous vortexing, nuclei were pelleted and resuspended in buffer C (20 mm HEPES, pH 7.9; 420 mm NaCl; 1.5 mm MgCl2; 0.2 mm EDTA; 25% glycerol; 0.5 mm phenylmethylsulfonylfluoride; 1 mm dithiothreitol; protease inhibitor). Samples were then agitated intermittently, kept on ice for 20 min, and spun down. Nuclear extract (supernatant) was loaded on 4–12% Invitrogen Nupage gel. Nur77 antibody (Cell Signaling Technology, Beverly, MA) was used at 1:1000 dilution and HMG-1 (BD Pharmingen, Franklin Lakes, NJ) at 1:5000.
Statistics
We performed statistical analysis using the Student’s t test, with significance determined a priori at P < 0.05.
Supplementary Material
[Supplemental Data]
Click here to view.
Acknowledgments
We thank K. W. Park and S. Hummasti for discussions. We also thank B. Spiegelman for providing 3T3-L1 hCAR cells and E. Saez for providing 3T3-F442A cells.
Footnotes
This work was supported by National Institutes of Health Grant HL30568 (to P.T.). L.C.C. was a Fellow of the Pediatric Scientist Development Program (National Institute of Child Health and Human Development Grant Award K12-HD00850). P.T. is an Investigator of the Howard Hughes Medical Institute.
Disclosure Statement: The authors have nothing to disclose.
First Published Online October 22, 2008
Abbreviations: 8-Br-cAMP, 8-Bromo-cAMP; CAR, coxsackie-adenovirus receptor; C/EBP, CCAAT enhancer binding protein; DMI cocktail, dexamethasone, isobutylmethylxanthine, and insulin cocktail; FBS, fetal bovine serum; GFP, green fluorescent protein; HEK, human embryonic kidney; IBMX, isobutylmethylxanthine; LPS, lipopolysaccharide; 2n, diploid; NR4A, nuclear receptor 4A; PPAR, peroxisome proliferator-activated receptor.
References
  • Green H, Kehinde O 1975 An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19–27. [PubMed]
  • Green H, Kehinde O 1976 Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7:105–113. [PubMed]
  • Green H, Meuth M 1974 An established pre-adipose cell line and its differentiation in culture. Cell 3:127–133. [PubMed]
  • Rosen ED 2005 The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 73:31–34. [PubMed]
  • Rosen ED, Spiegelman BM 2000 Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145–171. [PubMed]
  • Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM 1994 mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224–1234. [PubMed]
  • Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 79:1147–1156. [PubMed]
  • Perlmann T, Wallen-Mackenzie A 2004 Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res 318:45–52. [PubMed]
  • Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM 1998 Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 95:4013–4018. [PubMed]
  • Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T 1997 Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248–250. [PubMed]
  • Mullican SE, Zhang S, Konopleva M, Ruvolo V, Andreeff M, Milbrandt J, Conneely OM 2007 Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 13:730–735. [PubMed]
  • Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P 2006 NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12:1048–1055. [PubMed]
  • Chao LC, Zhang Z, Pei L, Saito T, Tontonoz P, Pilch PF 2007 Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol Endocrinol 21:2152–2163. [PubMed]
  • Pearen MA, Myers SA, Raichur S, Ryall JG, Lynch GS, Muscat GE 2008 The orphan nuclear receptor, NOR-1, a target of β-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology 149:2853–2865. [PubMed]
  • Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM, Mangelsdorf DJ 2005 A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol Endocrinol 19:2437–2450. [PubMed]
  • Fu Y, Luo L, Luo N, Zhu X, Garvey WT 2007 NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem 282:31525–31533. [PubMed]
  • Au WS, Payne VA, O'Rahilly S, Rochford JJ 2008 The NR4A family of orphan nuclear receptors are not required for adipogenesis. Int J Obes (Lond) 32:388–392. [PubMed]
  • Martinez-Gonzalez J, Rius J, Castello A, Cases-Langhoff C, Badimon L 2003 Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ Res 92:96–103. [PubMed]
  • Tetradis S, Bezouglaia O, Tsingotjidou A 2001 Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology 142:663–670. [PubMed]
  • Martinez-Gonzalez J, Badimon L 2005 The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc Res 65:609–618. [PubMed]
  • Williams GT, Lau LF 1993 Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses. Mol Cell Biol 13:6124–6136. [PubMed]
  • Coppack SW 2001 Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349–356. [PubMed]
  • Xu H, Sethi JK, Hotamisligil GS 1999 Transmembrane tumor necrosis factor (TNF)-α inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem 274:26287–26295. [PubMed]
  • Pei L, Castrillo A, Chen M, Hoffmann A, Tontonoz P 2005 Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 280:29256–29262. [PubMed]
  • Pei L, Castrillo A, Tontonoz P 2006 Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol 20:786–794. [PubMed]
  • Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, Muscat GE 2005 Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the β-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 280:12573–12584. [PubMed]
  • Pearen MA, Ryall JG, Maxwell MA, Ohkura N, Lynch GS, Muscat GE 2006 The orphan nuclear receptor, NOR-1, is a target of β-adrenergic signaling in skeletal muscle. Endocrinology 147:5217–5227. [PubMed]
  • Woronicz JD, Calnan B, Ngo V, Winoto A 1994 Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367:277–281. [PubMed]
  • Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS 2000 Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290:134–138. [PubMed]
  • Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C, Sul HS 2003 Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 111:453–461. [PubMed]
  • Smas CM, Sul HS 1993 Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73:725–734. [PubMed]
  • Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J 1995 Cardiac malformation in neonatal mice lacking connexin43. Science 267:1831–1834. [PubMed]
  • Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z 2007 The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13:486–491. [PubMed]
  • Yanagiya T, Tanabe A, Hotta K 2007 Gap-junctional communication is required for mitotic clonal expansion during adipogenesis. Obesity (Silver Spring) 15:572–582. [PubMed]
  • Clark TG, Conway SJ, Scott IC, Labosky PA, Winnier G, Bundy J, Hogan BL, Greenspan DS 1999 The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart. Development 126:2631–2642. [PubMed]
  • Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDougald OA 2002 Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem 277:38239–38244. [PubMed]
  • Schutze N, Noth U, Schneidereit J, Hendrich C, Jakob F 2005 Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun Signal 3:5. [PubMed]
  • Tang QQ, Otto TC, Lane MD 2003 Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci USA 100:44–49. [PubMed]
  • Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K 2007 Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148:868–877. [PubMed]
  • Dehaye JP, Winand J, Christophe J 1977 Lipolysis and cyclic AMP levels in epididymal adipose tissue of obese-hyperglycaemic mice. Diabetologia 13:553–561. [PubMed]
  • Begin-Heick N 1996 β-Adrenergic receptors and G-proteins in the ob/ob mouse. Int J Obes Relat Metab Disord 20(Suppl 3):S32–S35. [PubMed]
  • Gettys TW, Ramkumar V, Uhing RJ, Seger L, Taylor IL 1991 Alterations in mRNA levels, expression, and function of GTP-binding regulatory proteins in adipocytes from obese mice (C57BL/6J-ob/ob). J Biol Chem 266:15949–15955. [PubMed]
  • Fox KE, Fankell DM, Erickson PF, Majka SM, Crossno Jr JT, Klemm DJ 2006 Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) α, C/EBP β, or PPAR γ 2. J Biol Chem 281:40341–40353. [PubMed]
  • Nomiyama T, Nakamachi T, Gizard F, Heywood EB, Jones KL, Ohkura N, Kawamori R, Conneely OM, Bruemmer D 2006 The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J Biol Chem 281:33467–33476. [PubMed]
  • Zhang JW, Tang QQ, Vinson C, Lane MD 2004 Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 101:43–47. [PubMed]
  • Bezy O, Elabd C, Cochet O, Petersen RK, Kristiansen K, Dani C, Ailhaud G, Amri EZ 2005 Δ-Interacting protein A, a new inhibitory partner of CCAAT/enhancer-binding protein β, implicated in adipocyte differentiation. J Biol Chem 280:11432–11438. [PubMed]
  • Tang QQ, Otto TC, Lane MD 2003 CCAAT/enhancer-binding protein β is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci USA 100:850–855. [PubMed]
  • Azarnia R, Russell TR 1985 Cyclic AMP effects on cell-to-cell junctional membrane permeability during adipocyte differentiation of 3T3-L1 fibroblasts. J Cell Biol 100:265–269. [PubMed]
  • Bourlier V, Zakaroff-Girard A, De Barros S, Pizzacalla C, de Saint Front VD, Lafontan M, Bouloumie A, Galitzky J 2005 Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation. J Pharmacol Exp Ther 312:1272–1279. [PubMed]
  • Bouloumie A, Sengenes C, Portolan G, Galitzky J, Lafontan M 2001 Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50:2080–2086. [PubMed]
  • Liu J, DeYoung SM, Zhang M, Cheng A, Saltiel AR 2005 Changes in integrin expression during adipocyte differentiation. Cell Metab 2:165–177. [PubMed]
  • Patrick Jr CW, Wu X 2003 Integrin-mediated preadipocyte adhesion and migration on laminin-1. Ann Biomed Eng 31:505–514. [PubMed]
  • Hummasti S, Laffitte BA, Watson MA, Galardi C, Chao LC, Ramamurthy L, Moore JT, Tontonoz P 2004 Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. J Lipid Res 45:616–625. [PubMed]
  • Schmid I, Hausner MA, Cole SW, Uittenbogaart CH, Giorgi JV, Jamieson BD 2001 Simultaneous flow cytometric measurement of viability and lymphocyte subset proliferation. J Immunol Methods 247:175–186. [PubMed]
  • Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG, Greenberg AS 1998 Overexpression of perilipin A and B blocks the ability of tumor necrosis factor α to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 273:24665–24669. [PubMed]
Articles from Molecular Endocrinology are provided here courtesy of
The Endocrine Society

PubMed articles by these authors
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph